Dynamk Capital shares insights on disruptive Organ-on-a-Chip (OOAC)

Dr Gustavo Mahler, Venture Partner & and Jessica Davis, Venture Associate recently shared their insights on the disruptive new testing model referred to as Organ-on-a-Chip (OOAC) in a recent Pharma’s Almanac article.